Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616180695> ?p ?o ?g. }
- W2616180695 endingPage "242" @default.
- W2616180695 startingPage "234" @default.
- W2616180695 abstract "Pharmacologic challenge with sodium channel blockers is part of the diagnostic workout in patients with suspected Brugada syndrome. The test is overall considered safe but both ajmaline and flecainide detain well known pro-arrhythmic properties. Moreover, the treatment of patients with life-threatening arrhythmias during these diagnostic procedures is not well defined. Current consensus guidelines suggest to adopt cautious protocols interrupting the sodium channel blockers as soon as any ECG alteration appears. Nevertheless, the risk of life-threatening arrhythmias persists, even adopting a safe and cautious protocol and in absence of major arrhythmic risk factors. The authors revise the main published case studies of sodium channel blockers challenge in adults and in children, and summarize three cases of untreatable ventricular arrhythmias discussing their management. In particular, the role of advanced cardiopulmonary resuscitation with extra-corporeal membrane oxygenation is stressed as it can reveal to be the only reliable lifesaving facility in prolonged cardiac arrest." @default.
- W2616180695 created "2017-05-26" @default.
- W2616180695 creator A5006405170 @default.
- W2616180695 creator A5010865467 @default.
- W2616180695 creator A5015617603 @default.
- W2616180695 creator A5021196395 @default.
- W2616180695 creator A5022768342 @default.
- W2616180695 creator A5023710271 @default.
- W2616180695 creator A5036891706 @default.
- W2616180695 creator A5057695537 @default.
- W2616180695 creator A5073873421 @default.
- W2616180695 creator A5077901945 @default.
- W2616180695 creator A5078494446 @default.
- W2616180695 creator A5081857087 @default.
- W2616180695 date "2017-05-17" @default.
- W2616180695 modified "2023-09-27" @default.
- W2616180695 title "Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome" @default.
- W2616180695 cites W140924846 @default.
- W2616180695 cites W1490466277 @default.
- W2616180695 cites W1524320730 @default.
- W2616180695 cites W1649808976 @default.
- W2616180695 cites W175934965 @default.
- W2616180695 cites W1968209580 @default.
- W2616180695 cites W1968876226 @default.
- W2616180695 cites W1969311237 @default.
- W2616180695 cites W1974227886 @default.
- W2616180695 cites W1978235161 @default.
- W2616180695 cites W1980537973 @default.
- W2616180695 cites W1996112519 @default.
- W2616180695 cites W1996467787 @default.
- W2616180695 cites W1998419541 @default.
- W2616180695 cites W2007114137 @default.
- W2616180695 cites W2019885603 @default.
- W2616180695 cites W2021105832 @default.
- W2616180695 cites W2027136471 @default.
- W2616180695 cites W2031292103 @default.
- W2616180695 cites W2036056126 @default.
- W2616180695 cites W2042010116 @default.
- W2616180695 cites W2043681979 @default.
- W2616180695 cites W2045432956 @default.
- W2616180695 cites W2046794710 @default.
- W2616180695 cites W2057902453 @default.
- W2616180695 cites W2064756908 @default.
- W2616180695 cites W2068827735 @default.
- W2616180695 cites W2082337549 @default.
- W2616180695 cites W2091779216 @default.
- W2616180695 cites W2092718460 @default.
- W2616180695 cites W2098382690 @default.
- W2616180695 cites W2099365321 @default.
- W2616180695 cites W2109622977 @default.
- W2616180695 cites W2111107443 @default.
- W2616180695 cites W2112044702 @default.
- W2616180695 cites W2112137331 @default.
- W2616180695 cites W2113359250 @default.
- W2616180695 cites W2119052397 @default.
- W2616180695 cites W2122455147 @default.
- W2616180695 cites W2129087585 @default.
- W2616180695 cites W2129337686 @default.
- W2616180695 cites W2132741531 @default.
- W2616180695 cites W2133204526 @default.
- W2616180695 cites W2136071898 @default.
- W2616180695 cites W2144237838 @default.
- W2616180695 cites W2147325702 @default.
- W2616180695 cites W2147490644 @default.
- W2616180695 cites W2149984293 @default.
- W2616180695 cites W2151832186 @default.
- W2616180695 cites W2156113804 @default.
- W2616180695 cites W2170793251 @default.
- W2616180695 cites W2178421166 @default.
- W2616180695 cites W2185762742 @default.
- W2616180695 cites W2279412383 @default.
- W2616180695 cites W2297499338 @default.
- W2616180695 cites W2397449854 @default.
- W2616180695 cites W2547949531 @default.
- W2616180695 cites W2548446013 @default.
- W2616180695 cites W2616249537 @default.
- W2616180695 cites W40217535 @default.
- W2616180695 doi "https://doi.org/10.1093/europace/eux092" @default.
- W2616180695 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28521022" @default.
- W2616180695 hasPublicationYear "2017" @default.
- W2616180695 type Work @default.
- W2616180695 sameAs 2616180695 @default.
- W2616180695 citedByCount "21" @default.
- W2616180695 countsByYear W26161806952018 @default.
- W2616180695 countsByYear W26161806952019 @default.
- W2616180695 countsByYear W26161806952020 @default.
- W2616180695 countsByYear W26161806952021 @default.
- W2616180695 countsByYear W26161806952022 @default.
- W2616180695 countsByYear W26161806952023 @default.
- W2616180695 crossrefType "journal-article" @default.
- W2616180695 hasAuthorship W2616180695A5006405170 @default.
- W2616180695 hasAuthorship W2616180695A5010865467 @default.
- W2616180695 hasAuthorship W2616180695A5015617603 @default.
- W2616180695 hasAuthorship W2616180695A5021196395 @default.
- W2616180695 hasAuthorship W2616180695A5022768342 @default.
- W2616180695 hasAuthorship W2616180695A5023710271 @default.
- W2616180695 hasAuthorship W2616180695A5036891706 @default.
- W2616180695 hasAuthorship W2616180695A5057695537 @default.